Skip to main content Skip to navigation

Sarissa demonstrates pioneering biosensor technology


Sarissa demonstrates pioneering biosensor technology

Leading biosensor device manufacturer, Sarissa Biomedical, will be demonstrating its world-leading technologies at an event at the University of Warwick on 2 April 2012.

The University of Warwick spin-out company designs and manufactures a unique range of biosensors, which are used in research laboratories worldwide to enable researchers to better understand the chemical markers of major diseases.

Sarissa’s biosensors are able to detect not only how much of a particular chemical substance is present in a tissue sample, but when and where it is being produced. Monitoring the presence of these biochemicals in the body can yield important clues about the functioning of the body’s nervous system.

Results are recorded in real time, enabling researchers and clinicians to gain answers to questions that existing biosensing technologies have so far failed to address.

The company, set up in 2002 with assistance from Warwick Ventures, has grown significantly to become a world leader in the biosensor market.

Sarissa’s workshop, to be held in the University’s School of Life Sciences, will give existing and prospective customers the chance to find out more about the different biosensors Sarissa offers and how they can help their research, while experts will offer hands-on training in the use of the technology.

Nick Dale (pictured), CEO at Sarissa Biomedical says: “Sarissa’s biosensors offer researchers a much fuller understanding of biochemical processes than any existing technologies. As researchers are increasingly able to prove links between biomarkers and specific medical conditions, our biosensors could become increasingly important in disease diagnosis. This workshop is an important platform for us to demonstrate our technology and what it can achieve.”

Keynote speakers at the event will include Phil Haydon, Chair of Neuroscience at Tufts University in Boston, and Angus Brown, Associate Professor of Neuroscience, at the University of Nottingham Medical School.

Dr Haydon’s most recent work has focused on the role of astrocytes, a type of brain cell, on epilepsy, sleep disorders and depression, while Dr Brown studies energy metabolism in the brain. Both researchers use Sarissa’s biosensors in their research.

For more information visit the Sarissa Biomedical website.